INNT
TOTAL INVALIDATION PROCESSED BY THE IB
14/01/2022
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Descrição da marca
The mark consists of the wording "EXIQON" appearing above the words "Seek Find Verify" with all the aforementioned wording appearing in the color blue.
Titulares
Representantes
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical products for diagnostic, industrial and scientific purposes, namely, industrial chemicals, catalysts for chemical and biochemical processes and chemicals used in the manufacture of pharmaceuticals and drug candidates, all of the aforementioned being for use in life science research, for use in the manufacture of anti-cancer drugs and drug candidates, and for use in in vitro diagnostics and in molecular and cancer diagnostics not for medical or veterinary purposes; Biochemical products for analyses of nucleic acids, nucleotides, oligonucleotides, DNA and RNA, namely, biochemical catalyst, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays not for medical or veterinary purposes, and molecular and cell-based oncology assays not for medical and veterinary purposes; Chemical reagents not for medical or veterinary purposes; Biochemical kits, consisting of biochemical preparations in the nature of biochemical catalysts, biochemical reagents commonly known as probes, and enzymes, for analysis of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA not for medical or veterinary purposes; Biochemical reagents, commonly known as probes for analyses of DNA, RNA, nucleotides, oligonucleotides, nucleic acids and for detecting RNA and microRNA not for medical or veterinary purposes
Classe 5
Chemical preparations for pharmaceutical, medical and veterinary use, namely, clinical medical reagents, diagnostic reagents, and assays for medical use; Chemico-pharmaceutical preparations, namely, biomedical preparations and assays for use in the detection of cancer in humans and animals and for use in oncology and pharmaceutical preparations for use in the prevention, treatment and cure of cancer; Chemical reagents for medical and veterinary purposes; Chemical preparations for medical therapeutic purposes, namely, preparations for the detection of cancer in humans and animals, for the treatment, prevention and cure of cancer, and for use in oncology; Diagnostic preparations for medical and veterinary purposes
Classe 42
Scientific research, development and consultancy relating thereto in the fields of chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Biotechnological consultancy relating to DNA peptide and nucleotide syntheses
Classe 45
[ Licensing of intellectual property rights, including patent utilisation concerning chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Consultancy services concerning the issuing of intellectual property rights licenses, and of licenses relating to the use of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA ]
Histórico de despachos e eventos da marca no USPTO.
57 publicações encontradas
TOTAL INVALIDATION PROCESSED BY THE IB
14/01/2022
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
16/12/2021
INVALIDATION PROCESSED
16/12/2021
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26/10/2021
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2021
CANCELLED SECTION 71
26/02/2021
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/01/2020
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/01/2020
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29/06/2019
NEW REPRESENTATIVE AT IB RECEIVED
19/04/2019
CHANGE OF OWNER RECEIVED FROM IB
15/03/2019
INTERNATIONAL REGISTRATION RENEWED
12/04/2018
NEW REPRESENTATIVE AT IB RECEIVED
30/06/2017
PARTIAL INVALIDATION PROCESSED BY THE IB
23/06/2017
GENERIC MADRID TRANSACTION SENT TO IB
02/03/2017
GENERIC MADRID TRANSACTION CREATED
02/03/2017
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
27/12/2016
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
27/04/2016
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
27/04/2016
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/04/2016
TEAS SECTION 71 & 15 RECEIVED
04/03/2016
NEW REPRESENTATIVE AT IB RECEIVED
27/11/2015
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2013
FINAL DISPOSITION NOTICE SENT TO IB
06/10/2010
FINAL DISPOSITION PROCESSED
06/10/2010
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/09/2010
REGISTERED-PRINCIPAL REGISTER
29/06/2010
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/06/2010
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/05/2010
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/05/2010
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/04/2010
PUBLISHED FOR OPPOSITION
13/04/2010
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2010
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2010
EXAMINER'S AMENDMENT ENTERED
10/03/2010
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/03/2010
EXAMINERS AMENDMENT E-MAILED
10/03/2010
EXAMINERS AMENDMENT -WRITTEN
10/03/2010
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/02/2010
ASSIGNED TO LIE
25/02/2010
TEAS VOLUNTARY AMENDMENT RECEIVED
24/02/2010
FINAL REFUSAL MAILED
08/10/2009
FINAL REFUSAL WRITTEN
07/10/2009
TEAS/EMAIL CORRESPONDENCE ENTERED
25/08/2009
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/08/2009
ASSIGNED TO LIE
25/08/2009
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2009
REFUSAL PROCESSED BY IB
06/03/2009
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/02/2009
REFUSAL PROCESSED BY MPU
10/02/2009
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/02/2009
NON-FINAL ACTION WRITTEN
09/02/2009
ASSIGNED TO EXAMINER
29/01/2009
APPLICATION FILING RECEIPT MAILED
19/12/2008
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/12/2008
NEW APPLICATION ENTERED
15/12/2008
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/12/2008
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.